|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: PELICAN PROPERTIES INTERNATIONAL CORP, 10QSB, 2000-11-13 |
Next: ALKERMES CLINICAL PARTNERS LP, 10-Q, 2000-11-13 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 238390
<SECURITIES> 0
<RECEIVABLES> 160923
<ALLOWANCES> 0
<INVENTORY> 47937
<CURRENT-ASSETS> 492463
<PP&E> 18030813
<DEPRECIATION> (1634572)
<TOTAL-ASSETS> 17368570
<CURRENT-LIABILITIES> 3148097
<BONDS> 0
0
0
<COMMON> 5975
<OTHER-SE> 2770969
<TOTAL-LIABILITY-AND-EQUITY> 17368570
<SALES> 5844078
<TOTAL-REVENUES> 6153486
<CGS> 2203192
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 4130835
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 609168
<INCOME-PRETAX> (789709)
<INCOME-TAX> 227000
<INCOME-CONTINUING> (562709)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (562709)
<EPS-BASIC> 0
<EPS-DILUTED> 0
</TABLE>
|
|